Pınar Obakan-Yerlikaya

19PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 24, 2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.

|Feb 16, 2026
Chemopreventive Effects of Lycopene in miR-21 Knockout and Wild-Type Pancreatic Cancer Cells.

Basak Dalbayrak, Burcu Taluğ Taştan, Tuğçe Temel

|Aug 03, 2023
The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing.

Pelin Özfiliz Kilbaş, Gizem Alkurt, Pinar Obakan Yerlikaya

|Aug 02, 2023
Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells.

Pınar Obakan Yerlikaya, Leila Mehdizadehtapeh, Özge Rencüzoğullari

|Aug 02, 2023
The protective impact of growth hormone against rotenone-induced apoptotic cell death via acting on endoplasmic reticulum stress and autophagy axis.

Özge Berrak Rencüzoğullari, Selay Tornaci, Yağmur Çelik

|Nov 26, 2021
miR27a, a fine-tuning molecule, interacts with growth hormone (GH) signaling and ornithine decarboxylase (ODC) via targeting STAT5.

Ajda Coker-Gurkan, Kadriye Koyuncu, Pinar Obakan Yerlikaya

Pageof 4

Frequent Collaborators

13 joint publications

Elif-Damla Arisan

10 joint publications

Ajda Coker-Gurkan

6 joint publications

Ozge Rencuzogulları

4 joint publications

Narcin Palavan-Unsal